Age of the company
-Turnover in CHF
-Capital in CHF
-Employees
-Active brands
-Reports for Auregen BioTherapeutics SA
There is no information available because this company has been deleted.
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
Commercial register information
Entry in the commercial register
12.04.2017
Deletion from the commercial register
27.07.2023
Legal form
Branch with head office in Switzerland
Legal headquarters of the company
Zürich
Commercial Registry Office
ZH
Commercial register number
CH-020.9.004.845-8
UID/VAT
CHE-309.180.921
Sector
Research and development
Purpose (Original language)
Recherche, développement, mise à l'essai, production et marketing de produits dans le domaine des sciences de la vie (cf. statuts pour but complet).
Other company names
Es sind keine früheren oder übersetzten Firmannamen vorhanden.
Would you like to update the company name? Click here.Head office
Other branches (0)
Ownership structure
Holdings
Newest SOGC notifications: Auregen BioTherapeutics SA
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR03-1005804981, Commercial Registry Office Zurich, (20)
Auregen BioTherapeutics SA, in Zürich, CHE-309.180.921, schweizerische Zweigniederlassung (SHAB Nr. 51 vom 14.03.2019, Publ. 1004587245).
Hauptsitz in:
Genf. Infolge Aufhebung dieser Zweigniederlassung wird der auf sie bezügliche Eintrag im Handelsregister gelöscht.
Publication number: HR02-1004587245, Commercial Registry Office Zurich, (20)
Auregen BioTherapeutics SA, in Zürich, CHE-309.180.921, schweizerische Zweigniederlassung (SHAB Nr. 75 vom 19.04.2017, S.0, Publ. 3472897).
Hauptsitz in:
Genf.
Domizil neu:
c/o Regus Business Centers AG, Dreikönigstrasse 31A, 8002 Zürich.
Publication number: 3472897, Commercial Registry Office Zurich, (20)
Auregen BioTherapeutics SA, in Zürich, CHE-309.180.921, c/o ETH Zürich, ieLab, HPL D16.2, Otto-Stern-Weg 7, 8093 Zürich ETH-Hönggerberg, Zweigniederlassung (Neueintragung).
Identifikationsnummer Hauptsitz:
CHE-405.423.634.
Firma Hauptsitz:
Auregen BioTherapeutics SA.
Rechtsform Hauptsitz:
Aktiengesellschaft.
Hauptsitz:
Genf.